Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT00088894 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

590

Enrollment

NIH

Sponsor class

Conditions

Adenocarcinoma of the Pancreas
Recurrent Pancreatic Cancer
Stage II Pancreatic Cancer
Stage III Pancreatic Cancer
Stage IV Pancreatic Cancer

Interventions

DRUG: gemcitabine hydrochloride
BIOLOGICAL: bevacizumab
OTHER: placebo
OTHER: laboratory biomarker analysis
OTHER: pharmacogenomic studies
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)